Antisense enzyme inhibitors for metabolic redirection

Details for Australian Patent Application No. 2001263197 (hide)

Owner The Board of Regents of the University of Nebraska

Inventors Iversen, Patrick L

Agent FB Rice

Pub. Number AU-B-2001263197

PCT Pub. Number WO01/87286

Priority 09/737,452 13.12.00 US; 09/574,570 17.05.00 US

Filing date 16 May 2001

Wipo publication date 26 November 2001

Acceptance publication date 9 November 2006

International Classifications

A61K 31/00 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

19 February 2004 Assignment before Grant

  AVI BioPharma, Inc. The application has been assigned to The Board of Regents of the University of Nebraska

9 November 2006 Application Accepted

  Published as AU-B-2001263197

8 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001263198

2001263196